Does GEMZAR Cause Malignant neoplasm progression? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Malignant neoplasm progression have been filed in association with GEMZAR. This represents 11.3% of all adverse event reports for GEMZAR.
15
Reports of Malignant neoplasm progression with GEMZAR
11.3%
of all GEMZAR reports
6
Deaths
9
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GEMZAR?
Of the 15 reports, 6 (40.0%) resulted in death, 9 (60.0%) required hospitalization, and 2 (13.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMZAR. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does GEMZAR Cause?
Anaemia (14)
Off label use (13)
Pleural effusion (13)
Pyrexia (13)
Interstitial lung disease (12)
Decreased appetite (10)
Diarrhoea (10)
Renal failure acute (10)
Lung disorder (9)
Thrombocytopenia (9)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)